NASDAQ:KRON

Kronos Bio News Headlines

$22.89
-2.52 (-9.92 %)
(As of 04/13/2021 12:00 AM ET)
Add
Compare
Today's Range
$22.74
Now: $22.89
$25.88
50-Day Range
$25.41
MA: $28.52
$29.51
52-Week Range
$22.74
Now: $22.89
$39.60
Volume347,372 shs
Average Volume184,458 shs
Market Capitalization$1.28 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Kronos Bio (NASDAQ KRON) News Headlines Today

SourceHeadline
Kronos Bio (NASDAQ:KRON) Sees Unusually-High Trading VolumeKronos Bio (NASDAQ:KRON) Sees Unusually-High Trading Volume
americanbankingnews.com - April 13 at 11:52 AM
Jakob Loven Sells 15,828 Shares of Kronos Bio, Inc. (NASDAQ:KRON) StockJakob Loven Sells 15,828 Shares of Kronos Bio, Inc. (NASDAQ:KRON) Stock
americanbankingnews.com - April 12 at 10:32 PM
Kronos Bio, Inc. (NASDAQ:KRON) Director Jakob Loven Sells 63,128 SharesKronos Bio, Inc. (NASDAQ:KRON) Director Jakob Loven Sells 63,128 Shares
americanbankingnews.com - April 12 at 10:32 PM
Kronos Bio (NASDAQ:KRON) Hits New 12-Month Low at $25.32Kronos Bio (NASDAQ:KRON) Hits New 12-Month Low at $25.32
americanbankingnews.com - April 12 at 5:34 PM
Traders Purchase Large Volume of Kronos Bio Put Options (NASDAQ:KRON)Traders Purchase Large Volume of Kronos Bio Put Options (NASDAQ:KRON)
americanbankingnews.com - April 12 at 1:58 PM
What Type Of Shareholders Own The Most Number of Kronos Bio, Inc. (NASDAQ:KRON) Shares?What Type Of Shareholders Own The Most Number of Kronos Bio, Inc. (NASDAQ:KRON) Shares?
finance.yahoo.com - April 11 at 1:30 PM
Kronos Bio Presents Preclinical Data for Oral CDK9 Inhibitor KB-0742 Demonstrating Sustained Inhibition of Tumor Growth in Multiple Cancers at AACR Annual Meeting 2021Kronos Bio Presents Preclinical Data for Oral CDK9 Inhibitor KB-0742 Demonstrating Sustained Inhibition of Tumor Growth in Multiple Cancers at AACR Annual Meeting 2021
finance.yahoo.com - April 10 at 11:19 AM
Kronos Bio (NASDAQ:KRON) Stock Price Down 3.8%Kronos Bio (NASDAQ:KRON) Stock Price Down 3.8%
americanbankingnews.com - April 7 at 11:44 AM
Kronos Bio (NASDAQ:KRON) Sees Strong Trading VolumeKronos Bio (NASDAQ:KRON) Sees Strong Trading Volume
americanbankingnews.com - March 31 at 11:40 AM
Kronos Bio, Inc.s (NASDAQ:KRON) Lock-Up Period Will End  on April 7thKronos Bio, Inc.'s (NASDAQ:KRON) Lock-Up Period Will End on April 7th
americanbankingnews.com - March 31 at 1:10 AM
Kronos Bio Appoints Taiyin Yang, Ph.D., to Board of DirectorsKronos Bio Appoints Taiyin Yang, Ph.D., to Board of Directors
finance.yahoo.com - March 26 at 12:39 PM
Jefferies Financial Group Weighs in on Kronos Bio, Inc.s Q1 2021 Earnings (NASDAQ:KRON)Jefferies Financial Group Weighs in on Kronos Bio, Inc.'s Q1 2021 Earnings (NASDAQ:KRON)
americanbankingnews.com - March 26 at 7:04 AM
Kronos Bio, Inc. to Post Q1 2021 Earnings of ($0.45) Per Share, Piper Sandler Forecasts (NASDAQ:KRON)Kronos Bio, Inc. to Post Q1 2021 Earnings of ($0.45) Per Share, Piper Sandler Forecasts (NASDAQ:KRON)
americanbankingnews.com - March 26 at 7:04 AM
Kronos Bio (NASDAQ:KRON) Trading Down 7.7%Kronos Bio (NASDAQ:KRON) Trading Down 7.7%
americanbankingnews.com - March 25 at 11:37 AM
Brokers Set Expectations for Kronos Bio, Inc.s Q1 2022 Earnings (NASDAQ:KRON)Brokers Set Expectations for Kronos Bio, Inc.'s Q1 2022 Earnings (NASDAQ:KRON)
americanbankingnews.com - March 25 at 8:26 AM
Kronos Bio (NASDAQ:KRON) Shares Up 8.1% Following Strong EarningsKronos Bio (NASDAQ:KRON) Shares Up 8.1% Following Strong Earnings
americanbankingnews.com - March 24 at 11:10 AM
Kronos Bio (NASDAQ:KRON) Releases Quarterly  Earnings Results, Beats Estimates By $0.09 EPSKronos Bio (NASDAQ:KRON) Releases Quarterly Earnings Results, Beats Estimates By $0.09 EPS
americanbankingnews.com - March 24 at 7:48 AM
Kronos Bio Reports Recent Business Progress and Fourth Quarter and Full Year 2020 Financial ResultsKronos Bio Reports Recent Business Progress and Fourth Quarter and Full Year 2020 Financial Results
finance.yahoo.com - March 23 at 6:13 PM
Kronos Bio to Present Pre-Clinical Data at the AACR Virtual Annual Meeting 2021 for KB-0742, an Oral CDK9 Inhibitor Targeting MYC-amplified CancersKronos Bio to Present Pre-Clinical Data at the AACR Virtual Annual Meeting 2021 for KB-0742, an Oral CDK9 Inhibitor Targeting MYC-amplified Cancers
finance.yahoo.com - March 10 at 7:53 PM
The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic CompanyThe Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company
msn.com - March 4 at 9:43 AM
Kronos Bio Announces First Patient Dosed in Phase 1/2 Clinical Trial of KB-0742, an Oral CDK9 Inhibitor Targeting MYC-amplified CancersKronos Bio Announces First Patient Dosed in Phase 1/2 Clinical Trial of KB-0742, an Oral CDK9 Inhibitor Targeting MYC-amplified Cancers
finance.yahoo.com - February 25 at 12:23 PM
Kronos Bio Announces Participation in the Cowen 41st Annual Health Care ConferenceKronos Bio Announces Participation in the Cowen 41st Annual Health Care Conference
finance.yahoo.com - February 22 at 9:10 AM
Kronos Bio Appoints Marianne De Backer, Ph.D., to Board of DirectorsKronos Bio Appoints Marianne De Backer, Ph.D., to Board of Directors
finance.yahoo.com - January 26 at 8:45 AM
Kronos Bio, Inc. (KRON)Kronos Bio, Inc. (KRON)
finance.yahoo.com - January 20 at 9:57 PM
Have Insiders Been Buying Kronos Bio, Inc. (NASDAQ:KRON) Shares?Have Insiders Been Buying Kronos Bio, Inc. (NASDAQ:KRON) Shares?
finance.yahoo.com - January 11 at 3:05 PM
Kronos Bio Inc.Kronos Bio Inc.
barrons.com - December 11 at 10:50 PM
Kronos Bio Appoints Pasit Phiasivongsa, Ph.D., as Senior Vice President, Pharmaceutical DevelopmentKronos Bio Appoints Pasit Phiasivongsa, Ph.D., as Senior Vice President, Pharmaceutical Development
finance.yahoo.com - December 8 at 4:24 PM
Kronos Bio Announces FDA Clearance of Investigational New Drug (IND) Application for KB-0742, an Oral CDK9 Inhibitor Targeting MYC-amplified CancersKronos Bio Announces FDA Clearance of Investigational New Drug (IND) Application for KB-0742, an Oral CDK9 Inhibitor Targeting MYC-amplified Cancers
finance.yahoo.com - December 7 at 9:13 AM
Kronos Bio Announces Participation in Upcoming Investor ConferencesKronos Bio Announces Participation in Upcoming Investor Conferences
finance.yahoo.com - November 23 at 9:27 AM
Kronos Bio EPS misses by $4.10Kronos Bio EPS misses by $4.10
seekingalpha.com - November 18 at 12:59 PM
Kronos Bio Announces Participation in the Jefferies Virtual London Healthcare ConferenceKronos Bio Announces Participation in the Jefferies Virtual London Healthcare Conference
finance.yahoo.com - November 11 at 12:44 PM
Goldman Sachs: These 2 Stocks Have the Potential to Rally Over 40%Goldman Sachs: These 2 Stocks Have the Potential to Rally Over 40%
finance.yahoo.com - November 8 at 12:34 PM
Kronos Bio Announces Publication of Preclinical Study Results for Investigational CDK9 Inhibitor KB-0742 in Cell Chemical BiologyKronos Bio Announces Publication of Preclinical Study Results for Investigational CDK9 Inhibitor KB-0742 in Cell Chemical Biology
finance.yahoo.com - October 22 at 9:47 AM
Kronos Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesKronos Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
markets.businessinsider.com - October 14 at 6:22 PM
Kronos Bio IncKronos Bio Inc
reuters.com - October 13 at 12:18 PM
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.